EUVIMEDEUVIMED entdecken
Crossref

Machine Learning Based Classification Analysis of Benign and Malignant Breast Tumors: A Clinical Perspective

Harvendra Kumar, Arzoo Sorout, Ankul Tiwari, Priyanka Mishra, Yashi Bajpai, Prem Kumar

International Journal of Drug Delivery Technology · 17.06.2026 · 16 (55s)

DOI: 10.25258/ijddt.16.55s.62 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 17.06.2026. Verfasst von Harvendra Kumar und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a disease spared worldwide. Body's cells cultivate uncontrollably and reach to other parts of the body and propagate to other parts of bodies. As know all in general, cells grow and divide to produce new cells as the body requirements. Old or damaged cells die and are replaced by new cells. However, an old and damaged cell breaks down into cancer. Abnormal/damaged cells continue to live when they should die, and new cells form when they are no longer needed, such cells can form a tumor. One such cancer is known as breast cancer, and its early detection is crucial for the success of treatment and the survival of the patient. Accurate classification of skin lesions into malignant and benign categories is essential for timely treatment and reducing mortality rates. Various Machine Learning (ML) models are applied and compared for their effectiveness in diagnosing breast cancer using dermatological datasets. Performance measuring features accuracy, precision, recall, and F1-score are used to review the models. The promise of artificial intelligence as a reliable tool to assist dermatologists in clinical decision-making is highlighted by recent experimental results showing that specific algorithms perform better in diagnoses. In addition to improving diagnosis accuracy, the work helps create automated, dependable breast cancer detection systems that promote early intervention. The extensive use of AI and ML in breast cancer uncovering, diagnosis, and medication is transforming medical practice and improving how physicians detect and manage the disease. In this work, a labelled dataset of breast cancer has been used to compare Light Gradient Boosting (LightGBM) and Gradient Boosting. The Extreme Gradient Boosting (XGBoost) technique has been found to be more accurate than the LightGBM method.

Zitieren

APA

Kumar, H., Sorout, A., Tiwari, A., Mishra, P., Bajpai, Y., & Kumar, P. (2026). Machine Learning Based Classification Analysis of Benign and Malignant Breast Tumors: A Clinical Perspective. International Journal of Drug Delivery Technology, 16(55s). https://doi.org/10.25258/ijddt.16.55s.62

Vancouver

Kumar H, Sorout A, Tiwari A, Mishra P, Bajpai Y, Kumar P. Machine Learning Based Classification Analysis of Benign and Malignant Breast Tumors: A Clinical Perspective. International Journal of Drug Delivery Technology. 2026;16(55s). doi:10.25258/ijddt.16.55s.62

BibTeX
@article{Kumar2026,
  author = {Kumar, Harvendra and Sorout, Arzoo and Tiwari, Ankul and Mishra, Priyanka and Bajpai, Yashi and Kumar, Prem},
  title = {Machine Learning Based Classification Analysis of Benign and Malignant Breast Tumors: A Clinical Perspective},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {55s},
  doi = {10.25258/ijddt.16.55s.62}
}
Kostenlos starten →